Andrew C W Zannettino

Systematic screening identifies dual PI3K and mTOR inhibition as a conserved 2 therapeutic vulnerability in osteosarcoma 3

Elizabeth Stewart, Cathryn M. Gould, Anang A Shelat, 2015 .

Dysregulation of bone remodeling by imatinib mesylate.

K. Vandyke, S. Fitter, A. Zannettino, 2010, Blood.

An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration.

Justin J Cooper-White, Stan Gronthos, J. Cooper-White, 2013, Biomaterials.